Study Conduct

ACRES, Verified Clinical Trials partner to promote clinical trial safety

Thursday, April 10, 2014 01:45 PM

Verified Clinical Trials (VCT) and the Alliance for Clinical Research Excellence and Safety (ACRES) have launched a partnership.

More... »


CEO Roundtable on Cancer launches data-sharing initiative to accelerate drug development

Thursday, April 10, 2014 01:03 PM

By Ronald Rosenberg
CenterWatch Staff Writer

The CEO Roundtable on Cancer has launched Project Data Sphere, a new online oncology data-sharing platform using de-identified cancer patient information with the goal of accelerating drug discovery—by developing more efficient clinical trial protocols, epidemiological studies and, ultimately, new cancer therapies. 

More... »


WaveCheck receives $100,000 from Ontario Institute for Cancer Research

Wednesday, April 9, 2014 12:33 PM

WaveCheck has received a $100,000 catalyst grant from the Ontario Institute for Cancer Research (OICR). The funding builds upon MaRS Innovation's Indiegogo crowdfunding campaign for WaveCheck, which successfully raised over $50,000 from over 500 supporters worldwide over two months last fall.

More... »

Genentech, PatientsLikeMe enter patient-centric research collaboration

Wednesday, April 9, 2014 12:24 PM

PatientsLikeMe, a patient network and a real-time research platform, has formed a five-year agreement with Genentech, a member of the Roche Group, to explore using PatientsLikeMe’s global online patient network to develop innovative ways to research patients’ real-world experiences with disease and treatment. The agreement is the first broad research collaboration between PatientsLikeMe and a pharmaceutical company and provides PatientsLikeMe the opportunity to expand its patient network in oncology.

More... »

Tisch MS Research Center uses crowdfunding to finance clinical trial

Friday, April 4, 2014 11:07 AM

By Ronald Rosenberg
CenterWatch Staff Writer

Culminating 10 years of stem cell research for the treatment of progressive multiple sclerosis (MS), the Tisch MS Research Center in New York has raised more than $244,000 through donation-based crowdfunding in less than three weeks for a 20-patient phase I clinical trial that researchers say has the potential to repair the damage caused by the chronic disease that attacks the central nervous system.

More... »

Clinical Conductor CTMS releases first collaborative CTMS

Thursday, April 3, 2014 11:09 AM

Clinical Conductor, the industry’s first collaborative and configurable CTMS for organizations managing or executing clinical trials, created by Bio-Optronics, a provider of software and services to healthcare and life sciences organizations around the world, has released a new Clinical Conductor CTMS revolutionizing clinical trial collaboration. The financial capabilities of Clinical Conductor also have been strengthened by the release and provide users enhanced levels of clarity and granularity of their trial finances, allowing them to maximize profitability and more easily ensure billing compliance.

More... »

Society for Women’s Health Research urges FDA to require trials to examine gender-based differences

Wednesday, April 2, 2014 02:09 PM

Seeking to increase the participation of women and minorities in all phases of clinical trials, along with greater reporting and analysis of gender differences, Phyllis Greenberger testified at an FDA hearing yesterday. She presented a series of recommendations and changes to how the agency handles the collection, analysis and availability of demographic subgroup data in applications for FDA-regulated medical products.  

More... »

Annalisa Jenkins named IIR Partnerships’ Woman of the Year

Tuesday, April 1, 2014 01:43 PM

Annalisa Jenkins, former executive vice president, head of global R&D at Merck Serono, has been named IIR Partnerships’ Woman of the Year.

More... »

CISCRP launches inaugural 5K run and walk

Tuesday, March 25, 2014 02:51 PM

The Center for Information and Study on Clinical Research Participation (CISCRP), an independent nonprofit, is launching an annual 5K run and walk event in San Diego this June to celebrate the volunteers who give the gift of participation in clinical research.

More... »

Aptiv Solutions enables first surrogate endpoint-based adaptive clinical trials

Friday, March 21, 2014 11:05 AM

Aptiv Solutions, a global biopharmaceutical and medical device development services company, has released ADDPLAN 6.1, the first statistical software to enable the use of surrogate endpoints to expedite interim analysis decisions in adaptive clinical trials. With this tool, survival trials for cancer therapeutics and other trials with long-duration endpoints can now utilize adaptive designs to a far greater extent.

More... »

CenterWatch
CWWeekly

February 23

Venture capital investors funding novel drug R&D three times more than companies repurposing, improving existing drugs

In appreciation: Karen Woodin will be remembered for her teaching, writing and lasting friendships

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs